As China Reforms Drug Regulations, FDA Official Looks To Boost Collaboration
This article was originally published in The Tan Sheet
Executive Summary
FDA’s longtime China director, Chris Hickey, left for a position with Pfizer and Leigh Verbois takes the charge with a mission to further develop ties with the China FDA amid the Chinese regulator’s hectic efforts to jumpstart regulatory reforms.